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I. Background 
In much of the world, people in rural communities rely on medicinal plants as an affordable, 
accessible, and culturally relevant source of health care. However, in many cases, there has been 
little support for local health systems using these plants1, and research has primarily focused on 
ethnobotanical and phytochemical studies. Recently, though,interest in medicinal plants research 
...has increased dramaticalLy for a wide-range of reasons including an inability of many rural peoples 
and governments to afford western based pharmaceutical care, revitalization of indigenous 
knowledge and "traditional"2 health systems, a greater appreciation for local and indigenous 
knowledge, international concerns for the conservation of biodiversity, and income-generating 
potential. Similarly, the stakeholders involved are diverse and numerous, and include local peoples, 
local researchers, local NGO's, national ministries (health, agriculture, environment), international 
conservation agencies, development agencies, small, micro and medium enterprises, pharmaceutical 
companies, and others. 
IDRC currently supports a number of projects related to medicinal plants in several countries in 
Asia, Africa, and Latin America. As one might expect, there exists a wide range of projects which 
vary over their objectives, methodologies, and results. Although the centre has a long history of 
projects related to medicinal plants and/or traditional health, current projects are housed within the 
SUB PT, and thus are strongly linked to issues of biodiversity conservation. 
Recent documents from India (Cherla and Holley) and Africa (Dubé and Gasengayire) have 
contextualized medicinal plants issues in these regions, and identified needs and opportunities for 
medicinal plants research and development. These "needs" are based on discussions from regional 
and international meetings on medicinal plants issues, analysis of current research, and discussion 
with African and Indian researchers. This paper draws from these documents, along with reports 
from TRAMIL, project information, and other literature and discussion related to medicinal plants 
issues, in order to outline some of the fundamental issues which IDRC must prioritize and address in 
order to develop an informed strategy for medicinal plants research. Many of the project specific 
information given in this summary document is based on the concrete experience of the TRAMIL 
program. This is primarily because I had easier access to reports and information from the TRAMIL 
project than specific projects in Africa or South Asia, and is not intended to discount the valuable 
work of projects in these regions. 
This document is divided into three sections. The first section contains a brief overview of current 
IDRC actitivities in the three regions of research: South Asia, Africa, and Latin America. The 
Formal and governmental support given to health systems such as Ayurvedic, Chinese and Jamu systems in 
South and South East Asia are clear exceptions. 
2 have put "tradition" in quotation marks to emphasize the voice of many indigenous peoples who refer to 
their local health systems as "traditional health". The quotes are also to draw attention to the dynamic and evolving 
sense of tradition, rather than the notion of returning to a previous static way of life. "Traditional" health practices 
are constantly adapting and changing, and hence may also be thought of in terms such as "local" health practices. 
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second part presents a brief overview often priority issues, and identified research needs in these 
areas. Although these categories touch on a wide-range of issues, the topics are not mutually 
exclusive as there are strong interconnections with implications for research strategies and results. 
Finally, the last section concludes with a discussion of how these issues may relate to the 
development of a comprehensive and integrated strategy for medicinal plants research and 
preliminary steps needed to work towards this process. 
II. Regional Projects: 
IDRC currently supports medicinal plants projects with some or all of the following objectives 
(which vary depending on the project and the region): 
• conservation and sustainable use of biodiversity 
• improve access to local, safe, and effective health care 
• document indigenous knowledge 
• develop marketing and employment opportunities 
• networking 
i) South Asia 
Use of medicinal plants in South Asia has been classified under two "streams" of health care 
described as "classical systems" (e.g. Ayurvedic, Siddha, Tibetan) and "folk/tribal systems". 
While classical systems are recognized as formal health care systems, local folk/tribal systems 
have received less support and recognition. IDRC supports medicinal plants research in both of 
these streams. To date, projects are situated in South Asia: India, Sri Lanka, Nepal, and 
Bangladesh. 
The Neem project is one of the earliest IDRC medicinal projects in this region. In April, 1994, 
in response to a large number of proposals received on various aspects of medicinal plants 
research, IDRC (SARO office) initiated the IDRC Medicinal Plants Network (IMPN) based in 
New Delhi. IMPN aims to support projects in three main areas: 
1) Conservation and Cultivation - such as the development of sustainable ex-situ 
propagation techniques for ten commonly used Ayurvedic plants; baseline assessment of 
biodiversity of medicinal plants; and research in situ conservation strategies. 
2) Marketing and Enterprise - study of extraction and trade of medicinal plants 
3) Health and Medicine - projects related to the standardization of ayurvedic preparations 
for arthritis; training of rural people in green health kits; documentation of medicinal 
plant use. 
IMPN has also supported and participated in a number of conferences and workshops on 
medicinal plants research including: 
• National Consultation to Prepare a Draft National Medicinal Plants Conservation and 
Outline of National Programs for the Conservation of the Medicinal Plants of India 
Madras, India; 9-10 January 1997 
• South Asia Conference on Tribal and Folk Medicinal Plant Resources 
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Thirupati, India; 4-6 September 1996 
• Workshop on Role of Bamboo, Rattan and Medicinal Plants in Mountain Development 
Pokhara, Nepal; 15-17 May 1996 
• Workshop on Medicinal Plants 
Calicut, India; 6-8 February 1995 (Results published as Healing Forests, Healing People 
Bajaj and Williams 1995.) 
ii) Africa 
Traditional medicine(s) and medicinal plants are the primary sources of health care for most 
people in Africa. The diversity of traditional and local medical systems is remarkable, and 
dependent on cultural context. IDRC has a long history of medicinal plants (and traditional 
health) research in Africa, as evidenced in the Africa report, with projects dating back to 1974. 
Most research has focused on ethnobotanical and ethnotherapeutical documentation, 
biodiversity conservation of endangered and commonly used species, and the valorization of 
traditional medicine and medicinal plants. Some medicinal plants projects are directly linked to 
documentation of other biological resources such as foods. Recent projects are also beginning 
to focus on policy issues and research priorities3. 
See report by Dubé and Gasengayire for a comprehensive list of IDRC projects, abstracts, and 
contacts in Africa. 
iii) Latin America 
To date, IDRC supported research in this region has concentrated in Central America with the 
work of TRAMIL. TRAMIL (Traditional Medicine for the Islands) is a network of projects in 
the Caribbean basin (16 countries and 2 French islands) for the applied research and 
dissemination of knowledge and uses of medicinal plants. Research involves ethnobotanical 
studies using a uniform methodology and through dissemination workshops on TRAMIL 
medicinal plants for community health. The project has recently began a second phase with the 
long-term aim of developing locally based management programs for medicinal plants to meet 
communities' needs over their own health problems. Education and dissemination of 
information back to the communities is a strong component of these projects4. 
III. Priority Issues and Identified Needs 
Following is a brief discussion of some of the identified areas relating to medicinal plants requiring 
further research and support. At the end of each section is an overview of preliminary identified 
"needs", some of which are general to medicinal plants research, and others which are clearly 
Proj 96-5522 Medicinal Plants and Herbal Medicine in Africa: Policy Issues on Access, Ownership and 
Conservation. 
TRAMIL methodology is discussed in more detail in section (IH.v) Safety and Efficacy. 
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specific to IDRC. As will be evident, many issues are interconnected and fall under several of these 
ten categories: 
i. Conservation and Sustainable Use of Biodiversity 
ii. Health 
iii. Marketing and Employment 
iv. Networking 
v. Safety and Efficacy 
vi. Legislation and Policy Making 
vii. Indigenous Knowledge 
viii. Gender 
ix. Participatory Research and Community Participation 
x. Education and Dissemination of Information 
i) Conservation and Sustainable Use of Biodiversity 
There has been concern that the diversity of medicinal plants is diminishing and knowledge 
surrounding these plants is being lost, partly as a result of deforestation and habitat destruction, 
and also from cultural change and the loss of transfer of knowledge. In some cases, a lack of 
validation and institutional support given to local health practices has resulted in decreased use 
of plants and a loss of these resources. Alternatively, in other instances, overharvesting and 
exploitive trade have hindered the sustainable use of medicinal plants. Documentation and 
education of medicinal plants use are viewed as immediate and effective approaches to 
conserving the rich diversity of these resources. However, the TRAMIL programme has also 
acknowledged the conservation paradox: educating people about a plant's medicinal properties 
to encourage its use may lead to over-exploitation and unsustainable, haphazard use5. There is a 
critical need to develop appropriat (ëö-)riãiiàgethèhtstrategiès for the conservation and 
sustainable use of medicinal plants. 
To date, IDRC has supported a number ofprojects researching the identification of rare and 
endangered species, ethnobotanical surveys, and appropriate national and community-based 
conservation strategies. All regions have identified the need for further research in these areas 
and for extensive documentation of medicinal plants and related indigenous/local knowledge. 
The need for greater community participation and socio-cultural context has been emphasized. 




botanical gardens forest management 
national seed banks sacred groves 
In order to address this contradiction, the TRAMIL programme incorporates efforts to develop sustainable 
conservation strategies. 
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herbaria sustainable wild harvesting 
gene banks local (village) level seed banks 
home gardens community-based methods 
strategies for cultivation 
incentives for sustainable management 
rehabilitation of degraded lands 
Needs: 
• research, develop and implement appropriate (co-)management strategies for 
conservation and sustainable use 
• document local/indigenous knowledge and use of medicinal plants 
• identify rare and endangered species 
• increase community participation, participatory methodologies 
• facilitate control and access to resources by local and indigenous peoples 
ii) Health 
According to WI-JO, over 80% of the world's population rely on medicinal plants for health 
care. This is partly because, for many, allopathic medicines and treatment are unaffordable, but 
also because local health care and traditional medicines are more culturally and socially 
relevant. As Dubé and Gasengayire emphasize in the Africa report, it is critical to not view 
medicinal plants in isolation, but to recognize the intricate linkages between medicinal plants 
and local health systems, and the local health practitioners involved. 
At a recent IDRC supported workshop in Abidjan, Côte d'Ivoire (April 23-26, 1996), 
participants reviewed the general concepts and benefits of "traditional" medicine which 
included the "cultural and geographical proximity" to the patient. Other identified advantages 
include the richness and diversity of therapeutic approaches, the cultural significance of 
substances used, the modest cost of care and flexibility of payment mechanisms, the holistic 
dimension, and the greater availability of "traditional" therapists. These have been described as 
the 4 A's: availability, acceptability, accessibility, and adaptability (Anyinam 1987). However, 
"traditional" practitioners and plant-based pharmacopoeia generally are not supported as a 
national form of health care (excluding the Asian classical medical systems), and are often 
viewed as "backward", "witchdoctoring", unsafe and ineffective. Other constraints include the 
absence of consistent policy, the isolated context of "traditional" practitioners, and insufficient 
funds for research and development (Dubé and Gasengayire 1997). 
For the most part, local health care involves some combination of "traditional" medicine, 
allopathic treatment, and other classical systems (such as Ayurvedic medicine). Choice of 
treatment depends on the particular ailment and the economic, social, and cultural conditions; 
medicinal plants are generally used in the context of self-administered health care, local healers, 
and classical medical systems. As choice of health care is intricately linked to belief systems, 
research involving medicinal plants as a means of local accessible health care must be situated 
within an understanding of local health systems. Local communities and indigenous peoples 
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have explicitly argued for this need to consider the context of local and "traditional" health 
systems in medicinal plants research (see Bodeker 1996; GIFTS of Health6). 
Some of IDRC supported projects focus specifically on the health aspects of medicinal plants 
research. For example, the main objective of the TRAMIL project is to improve local access to 
safe, effective, and culturally appropriate health care. IMPN supports some projects relating to 
local health care and the standardization of medicines involved in the classical medical systems. 
Projects in Africa research the use and conservation of popularly used medicinal plants and 
involve local herbalists and practitioners. The aim has been to support existing systems and 
knowledge, rather than developing new health care or new medicines. The objective is not to 
deter from using western allopathic medicine, but to support accessible alternatives for health 
care which are inexpensive, locally relevant, and accessible to rural populations. 
Needs: 
• ensure safety and efficacy (see later section) 
• integration of local and modern medicine andlor recognition of the complementary nature 
of different health care systems 
• support formal government health care sector to use medicinal plants as part of health 
care policy 
• dissemination of information (e.g. project results; appropriate use of plants for health 
care) 
• facilitate co-operation between local health practitioners, government ministries, health 
care professionals 
• support the organization of local and traditional healers into local andlor national 
associations to facilitate collaboration, and to deal with the state, health care professionals 
and researchers with a unified voice. 
• work with local healers (associations) to support and promote the use of medicinal plants. 
• improve attitude and perception of health care professionals toward local health 
practitioners 
• develop methods for standardization and quality control at industrial level 
• support research of ethnoveterinary aspects of medicinal plants 
• support participatory research methodologies 
• education (e.g. training modules for educational curriculum) 
iii) Marketing and Employment 
The development of medicinal plants as a source for income generation has sparked interest 
among a number of stakeholders. As one might expect, this area covers a range of activities 
from small-scale local production, medium enterprise, large-scale industrial use, and 
6 The GIFTS of Health initiative aims to promote research into, and the inclusion of, traditional health systems 
as significant components of affordable and sustainable health care in developing countries, including a specific 
emphasis on medicinal plants and biodiversity conservation. The program conducted regional conferences in South 
and Central America, Africa and Asia. Currently, the program is housed at Oxford. 
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international trade, and involves players at all stages of the market chain. Within IDRC, market 
interests have been discussed most extensively in the context of South Asia, as reflected in the 
recent India report's primary focus on the economic potential of these non-timber forest 
products (NTFPs). This report emphasizes the need for extensive research into marketing 
possibilities (and the lack of research to date) and the benefits of promoting the cultivation and 
sustainable harvesting of the plans that are the most viable in the marketplace. In this context, 
potential financial gains are seen as incentive for conservation and sustainable use of this 
resource. This revenue-generating approach is congruent with IDRC objectives to develop 
income opportunities. 
In Africa, UNIDO and WHO co-hosted a meeting in Brazzaville, Congo in November, 1995 on 
the promotion and development of the industrial use of medicinal plants. This widely attended 
conference identified a number of needs on national, regional, and international levels in order 
to facilitate the development of the medicinal plants industry. These included more systematic 
documentation on medicinal plants, their cultivation, R&D, and regulatory requirements and 
human resources and facilities for the industrial-scale production of standardized high-quality 
medicines (Dubé and Gasengayire p.78). To date, however, IDRC projects in Africa have not 
directly focused on the industrialization of medicinal plants. In Central America, phase II of 
TRAMIL includes a collaborative program which investigates the economic potential value of 
medicinal plants and aims to develop small-scale, conservation oriented enterprises. 
In order to promote the production of low-cost herbal medicines, the Africa report identifies the 
need to find simple technology, based on existing knowledge, that are applicable or adaptable to 
local manufacturing including standardized production, adequate quality control and 
preservation of products (Dubé and Gasengayire p.77) 
Needs. 
This area raises a number of areas requiring further research, albeit differing on the scale of 
industry: 
• standardized production and quality control 
• preservation of products 
• safety and efficacy 
• ensuring community/local benefits 
• IPR and ICPR7 protocols 
• protocols, legislation, and monitoring 
• potential marketable plants 
• role of "western" business interests (e.g. pharmaceutical companies) and definition of 
relationship of IDRC to "western" industry re: medicinal plants. 
• impact of industrialization of medicinal plants on local healers and health systems 
• potential impacts of the marketing plants, including cultivation (socio-economic, health, 
gender) 
ICPR is a term preferred by some indigenous groups and other organizations to include cultural rights and 
address the need to understand intellectual property rights in the context of the relevant culture. 
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iv) Networking 
There is an urgent need in medicinal plants research for networking, co-operation and cô- 
ordination. Although, a wealth of research and experience exists and a remarkable number of 
organizations and researchers are involved, there are few communication and networking 
structures in place. Structures are required to facilitate the exchange of information and 
experience and to co-ordinate activities on all levels: local, national, regional, and international; 
and to involve the various stakeholders interested in this research: local communities, local and 
"traditional" health practitioners (and associations), health care professionals, researchers, 
national governments and ministries (health, agriculture, environment), local and regional 
NGO's, international organizations, and the private sector. 
Currently, IDRC supports networks in all three regions: TRAMIL, IDRC Medicinal Plants 
Network (IMPN) in South Asia, and the development of a network in Africa. the context of 
these projects, a number of meetings and conferences have been held which have helped build 
linkages and develop strategies for approaching medicinal plants issues. There has been some 
discussion that IDRC may contribute to the development and management of a global network 
or secretariat. With the breadth of organizations and interests involved, co-ordinated and 
formalized communication systems are clearly needed. 
Bangalore meeting -- February '98 
This meeting is a follow-up of an International Consultation on the conservation of medicinal 
plants convened by WHO, IUCN, and \VWF, and held in Chiang Mai, Thailand in 1988 (see 
Akerele, Hewood, and Synge 1991). It is certain that this significant gathering will prove 
influential in determining global and local agendas for medicinal plants research, and provides 
an ideal opportunity for IDRC to communicate its experience, strategy, and existence in a global 
context of medicinal plants research. 
Needs. 
• facilitate networking, communication, and collaboration at national, regional, and 
international levels. 
This may include: 
• support local practitioners/traditional healers associations 
• facilitate linkages and co-operation among various stakeholders such as local researchers, 
traditional practitioners, national governments and ministries, local NGO's. 
• establish global network 
• network and co-ordinate with other international organizations (IUCN, WB, WHO) 
• identify and formalize communication with other networks (e.g. Asian Network on 
Medicinal and Aromatic Plants) and regional organizations involved in medicinal plants 
research 
• participate in upcoming regional and international meetings 
• collaborate with Canadian players 
• build linkages between IDRC supported networks (TRAMIL, IMPN, AFRICA) 
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v) Safety and Efficacy 
Safety is a priority issue in medicinal plants research, with particular relevance to the promotion 
of medicinal plants as a method of health care. While most projects involve testing, there is 
some concern that research and trials are inadequate to ensure safety in medicinal plants use. In 
addition, a lack of standardization, quality control, and monitoring processes have augmented 
concern about the safety and toxicity of medicinal plants. Generally, bibliographic information 
(from NAPRALERT8) is used in conjunction with laboratory testing and trials (LD50) to 
determine levels of toxicity. However, toxicity is dependent on preparation, use, and storage 
techniques. 
Efficacy is similarly a critical issue, yet to some degree, controversial. Generally, medicinal 
plants are initially identified by local peoples andlor healers as being effective treatment for a 
particular ailment. Testing for a plant's efficacy refers to a laboratory measure of the bio- 
chemically active ingredient in the plant compound in the treatment of the identified ailment. 
This information is sought through bibliographic searches and laboratory tests and trials. 
However, some people have raised concern that this may not be a true measure of efficacy as 
this testing process does not take into account other influential factors, such as synergism of 
drug activity, detoxification effects of traditional preparations, and the context of healing as 
effective treatment. 
Safety issues have been debated extensively among the IDRC Ethics Review Committee. 
Notably, the TRAMIL methodology has received positive review by IDRC staff and others in 
regards to its approach to safety and toxicity issues. Under the TRAIvIIL approach, plants are 
classified under one of 4 categories: 
1) REC - recommended (non-toxic, bio-chemically effective) 
2) TOX - toxic 
3) INV - investigate (more information needed) 
4) NOT REC - not recommended (non-toxic, not proven to be biochemically effective). 
This last category is a new addition. Previously, these plants would be put under the 
"investigate" category. TRAMIL does not promote or investigate plants used to address "life- 
threatening" diseases such as AIDS, cancer, malaria, or diabetes. Rather, the focus is on 
commonly used local remedies. 
Much concern and apprehension towards the use of medicinal plants stems from a lack of 
understanding of the safety and efficacy of their use. This negativity is augmented by perceived 
lack of hygiene in preparation and preservation of remedies, inaccuracy of diagnoses and 
dosages, and a view of local healing as "backward". Education, then, is vital to ensuring proper 
and appropriate use of medicinal plants. However, the logistics of ensuring safety and efficacy 
are amplified in the scale of industrial use of medicinal plants; there is a need for 
8 The Natural Products Alert (NAPRALERT) at the University of Illinois has documented the ethnomedicinal 
uses for more than 9,000 species, including monocotyledons, dicotyledons, gymnosperms, pteridophytes, 
bryophytes and lichens. 
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standardization and regulation of production, and means of monitoring to ensure quality 
production. 
Needs. 
to develop legislation and protocols for safety and efficacy9 
NB: The main objective of an upcoming International Symposium on Herbal Medicine is 
to formulate an international protocol which could serve to regulate the use of herbal 
medicine. This symposium is cosponsored by TJNIDO and the International Institute for 
Human Resource Development (San Diego State University) and will take place June 1- 
4, 1997. Gilles Forget will be attending. 
• emphasis on education to ensure proper and appropriate use of medicinal plants 
• standardization and regulation of production 
• develop monitoring mechanisms to ensure safety 
• communicate with other organizations and researchers successful strategies for 
approaching safety and efficacy issues (e.g. TRAMIL) 
• investigate considerations of efficacy beyond bio-chemical laboratory testing 
• facilitate access to bibliographic information and previous research; new and regionally 
accessible databases are needed. For example, the Africa report points to frustrations 
with NAPRALERT which is not easily accessible and does not include information 
available in other languages. 
vi) Legislation and Policy Making 
Multi-level policies and legislation are required to regulate the practice of herbal medicine and, 
the use of medicinal plants, standards of quality and standardized protocols for the production of 
plant medicines, and the preservation and marketing of medicinal plants (Dubé and 
Gasengayire). 
To date, IDRC projects have not focused on the development of policies and legislation 
specifically in the area of medicinal plants except for a recent IDRC project which investigates 
policy issues on access, ownership, and conservation of medicinal plants and herbal medicines 
in Africa (96-5522). However, IDRC, and the SUB P1, supports a number of initiatives in 
policy making, particularly related to the Convention on Biological Diversity, such as The 
Crucible Group's work in IPR IDRC may consider applying its experience in 
supporting the development of international policy and legislation to the area of medicinal 
plants research. 
Two documents prepared by WHO are viewed internationally as useful reference tools for proper evaluation 
of medicinal plants: Research directions for the safety and efficacy of herbal medicines and Directions for the 
evaluation of herbal medicines. 
JO See The Crucible Group (1994) Peoples Plants and Patents: the impact of intellectual property on trade, 
plant biodiveristy and rural society, Ottawa: IDRC; and Posey, Darrell (1996) Beyond Intellectual Property, 
Ottawa: IDRC. 
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Needs: 
Support the development of multi-level policy and legislation in the following areas: 
• standardized protocols for the production of plants medicines 
• quality standards and monitoring procedures 
• safety and efficacy regulations 
• IPRJICPR, compensation for indigenous knowledge" 
• botanical gardens and IPR issues 
This area builds on the JDRC/RAFI supported conference in Montreal which investigated 
the relationship of botanical gardens, industry, and local communities. Currently there is 
an undefined area of how donor countries and indigenous groups may receive 
compensation or IPR relating to botanical garden collections. 
• recognition of traditionalllocal medicines as part of official national health care policy 
• control over and access to biological resources by local and indigenous people 
• conservation and sustainable management of biological diversity 
vii) Indigenous Knowledge (1K) 
Increasing attention has been paid to the importance of indigenous and local knowledge of the 
environment and natural resources, and the vital role of this knowledge, and of local peoples, in 
the development of sustainable resource management strategies. Researchers are also 
increasingly acknowledging the "scientific" validity of 1K. With concern that indigenous 
knowledge is being lost with older generations and cultural change, there is a sense of urgency 
in the need to document the knowledge and use of medicinal plants. However, there exist a 
number of real and valid concerns over the process of documentation, control of and access to 
this knowledge, and ensuring benefits to local communities. Some peoples fear that this 
knowledge will be "stolen", and they will receive nothing in return, particularly when 
considering the involvement of multinational pharmaceutical companies and the development of 
a multi-billion dollar industry based on these plants and knowledge. Access and rights to 
knowlege, and related benefits, are discussed under the rubric of intellectual (and cultural) 
property rights. 
IPR/ICPR 
Further research is needed on the impact of intellectual (and cultural) property rights on the 
preservation and maintenance of traditional knowledge, innovations, and practices of indigenous 
and local communities, and the development of possible alternative agreements. IPR issues 
relevant to medicinal plants include "bioprospecting", relationships with pharmaceutical 
companies, patents, "shared benefits" and ultimately control over knowledge. 
To date, IDRC medicinal plants projects have not focused on IPR issues. One project has 
justified this by suggesting that since research focuses on non life-threatening ailments and on 
Some indigenous groups have called for a moratorium of research on medicinal plants until IPR regulations 
are in place. 
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commonly used remedies, and not a search for a "new" medicine, pharmaceutical companies 
and industry will not be interested. However, this does not discount the possibility of TPR 
issues developing at a later time, and warrants due consideration. 
Needs: 
• documentation of indigenous and local knowledge re: medicinal plants issues 
• participatory research methodologies 
• community control and access to knowledge 
• develop IPRJICPR legislation and protocols 
• sensitivity to "secrecy" of local practitioners 
• ensure locallcommunity benefits from research 
viii) Gender 
Many reports refer to the predominant role of women as providers of local and family health 
care, and as primary harvesters and "caretakers" of medicinal plants. However, little attention 
has been paid to issues of gender or gender relations in medicinal plants research. 
A few of IDRC supported projects have focused on women's use and knowledge of medicinal 
plants. A project in Africa has focused on women and biodiversity of food crops and medicinal 
herbs (93-0034). TRAMIL works primarily with mothers' and women's groups who are the 
primary source of community expertise for commonly used traditional remedies. In some cases, 
unfortunately, the label "gender" has been applied misappropriately to refer to the inclusion of a 
woman on the research team. 
The Africa and India reports both refer to the need for "participation of women at all levels". 
While the involvement of women is, without doubt, crucial, there is also a strong need to 
incorporate gender issues and analysis in all aspects of medicinal plants research. For example, 
gender considerations may include ways women and men are involved differently in the 
harvesting and use of medicinal plants, in choice and access to health care, and in the various 
stages of the marketing chain. Although women are currently the primary users and caretakers 
of medicinal plants, as research in this area acquires higher status and economic benefits, gender 
roles potentially could shift as some men may position themselves to receive more of the 
benefits. 
Needs: 
• integrate gender issues and gender analysis into projects 
• promote understanding of importance of gender issues among researchers 
• liaise with Gender and Sustainable Development Unit to obtain support in facilitating this 
process 
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ix) Participatory research and Community Participation 
As studies have noted, participatory research is successful not only in sustaining long-term 
research goals, but also in building local research capacity and facilitating community 
empowerment. All regions have highlighted the need to support and develop participatory 
research involving traditional practitioners and local communities. Local and indigenous 
peoples and researchers have strongly voiced the need for full participatory research in the area 
of medicinal plants. However, the term participatory research denotes a wide range of meanings 
for many different people, from full participation in the design, implementation, and analysis of 
a project to participation in the identification and collection of plants. It is critical to recognize 
the value of full "community" participation in the research process as a prerequisite to the 
success of long-term protection and conservation of medicinal plants. Participatory research 
must be supported at the earliest stages of the research process. 
Needs: 
• encourage participatory research involving communities and local health practitioners 
• support training in participatory research methodologies 
x) Education and Dissemination of Information 
Although some research supports local medicines and their applications, community health 
workers and others refrain from using them as they are unaware of the safety and efficacy of 
local remedies (TRAMIL report). There is a need to look beyond simply documenting this 
knowledge, and to consider how it may be best applied for use by local communities, 
practitioners or associations. This may include education of local women and mothers of ways 
to use some common plants for health care such as "green kits", or promotion of strategies for 
the conservation and sustainable use of popularly used species. Information and experience of 
projects must be communicated at multi-levels: to local peoples, national governments, 
regional associations, and to other researchers and organizations. 
Needs: 
• dissemination of information to local communities re: safe arid appropriate usage of 
medicinal plants; strategies for conservation and sustainable use 
• curriculum development to include "modules" on traditional medicines and 
pharmacopoeia in medical and health care programmes 
• communication of results and experiences of projects through networks, workshops and 
conferences, and publications 
• communicate information to national ministries in order to inform health policy 
• build research capacity and training in research methodologies 
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IV. Towards a Comprehensive Strategy 
I) IDRC and Medicinal Plants 
As described above, IDRC supports a diversity of projects in medicinal plants research, which 
vary in objectives and methodologies, and take place in differing contexts depending on the 
regions and countries involved. In developing an "IDRC strategy", then, it is critical to 
recognize the wide scope of projects, and to be sensitive to the uniqueness of local social, 
cultural, political, and economic contexts. 
With that said, it has also been suggested that IDRC's strength rests in the breadth of research 
that it supports. Alternatively, most (international) organizations generally focus on one 
primary area: for example, WHO concentrates on health issues, the World Bank focuses on the 
economic potential of medicinal plants, and the IUCN concentrates on biodiversity conservation 
aspects. In contrast, JDRC approaches medicinal plants in a more "holistic" manner, in 
recognizing the interconnections of these issues and incorporating research which addresses all 
of these objectives. Clearly, medicinal plants research comprises a number of interrelated 
issues, such as health care, conservation strategies, indigenous knowledge, and the 
commercialization of medicinal plant products, issues which cannot be considered in isolation. 
In addressing the inherent connections involved in medicinal plants research and many issues 
which are relevant to the SUB theme on a whole, IDRC is well situated to be comprehensive in 
its approach towards medicinal plants research. This integrated and comprehensive approach 
may further its position as an appropriate structure to facilitate a global network. 
ii) Ethical Considerations 
In working towards a comprehensive and informed strategy, it is critical to recognize that ethical 
issues are prevalent through each of these priority areas, and that these concerns have direct 
implications on the research process and results at both project and policy levels. As there are a 
number of stakeholders and interests involved in medicinal plants research, each with differing 
mandates, methodologies, and explectations, several questions arise regarding the research 
process. How is the "community" involved? Who is controlling the research? What happens 
to the knowledge after it is documented? Who retains control and access to this knowledge? 
Who benefits from the research and in what way? Is the research socially and culturally 
appropriate? What are the gender impacts of such research? Is this research promoting safe and 
effective alternatives to health care? Ethical considerations involve issues of the research 
process itself, such as participatory research, community involvement, gender issues, social and 
cultural relativity; and also incorporate broader implications of research such as IPRIICPR, 
health and safety, effects of marketing, and involvement with multi-national business. As these 
issues touch on many of the areas discussed above, it is critical to address ethical concerns at 
preliminary stages of developing a research strategy, as well as on an on-going basis. As a 
support agency, establishing our own position vis a vis these ethical issues, perhaps in the form 
of formalized ethical guidelines, will both aid in our strategy as well as providing a 
clear mandate to our research partners. 
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iii) Steps Towards Developing a Comprehensive Strategy 
In the development of a comprehensive and integrated strategy, it is critical to address the 
priority areas discussed above and situate IDRC's position and responsibilty to these of 
medicinal plants research. In clarifying our goals and objectives, it is similarly crucial to be 
sensitive to locally defined research needs and priorities. In this regard, communication and 
discussion both within the Medicinal Plants Working Group, and with our research partners, is 
key to the development of a successful strategy. Within IDRC, the Medicinal Plants Working 
Group is a fundamental structure to be involved in the formation of a cohesive approach, as this 
group cuts across disciplines, program initiatives, and regional offices. However, to ensure an 
effective and beneficial process with relevant and applicable results, it is essential that an 
effective communication strategy is developed first. Members may contribute their experience 
and expertise in assessing and prioritizing the research "needs", assessing internal capabilities, 
and working towards an informed strategy. It is also vital to consult directly with project 
researchers, and building strong network links will facilitate this process. In clarifying and 
focusing IDRC's approach to medicinal plants research, we will better be able to support our 
research partners as well as situating the Centre's position in the global arena. 
Following, then, are some preliminary steps towards developing an integrated strategy for 
medicinal plants research at IDRC: 
1) Identification of needs. 
2) Development of in-house communication strategy. 
3) Prioritization of needs. 
4) Review ethical considerations. 
5) Assessment of internal capabilities. 
6) Discussion paper of comprehensive strategy. 
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